Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sonnet Biotherapeutics Holdings Inc SONN

Consumer Cyclical Biotechnology
Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company with a proprietary platform for biologic medicines of single-or bifunctional action. Its technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. It designed the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SONN)

Sonnet BioTherapeutics Releases Virtual Investor '"What this Means" Segment

GlobeNewswire 9 days ago

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire November 6, 2024

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates

GlobeNewswire November 6, 2024

Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq

GlobeNewswire October 17, 2024

Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India

GlobeNewswire October 9, 2024

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

GlobeNewswire October 4, 2024

Sonnet BioTherapeutics Announces Launch of CEO Corner Platform

GlobeNewswire September 30, 2024

Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

GlobeNewswire September 25, 2024

Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors

GlobeNewswire September 18, 2024
View More News ››

Opinion & Analysis (NDAQ:SONN)

Natural gas shortage may drive (T.HNU) higher

Stockhouse Editorial January 22, 2014
View More Opinion ››

Bullboard Posts (NDAQ:SONN)

SONN..... The previous post was "the good news"....

Now here is "The Bad News"..... and I will say it now.....All the Chsers & FOMO's have been had...... AGAIN ! Sonnet...
Iseneschal - November 6, 2024

Sonnet BioTherapeutics Issued USTPO Patent Covering Two Nove

NEWS: $SONN Sonnet BioTherapeutics Issued USTPO Patent Covering Two Novel Immunotherapeutic Drug Candidates2024-11-06 08:53:45 ET DENVER...
whytestocks - November 6, 2024

SONN....$12 Holla

On watch  No position
Iseneschal - November 6, 2024

SONN....sold to America

Yeeehaaaa
Iseneschal - November 6, 2024

SONN....Kabooooom....huge news and rip

  Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel...
Iseneschal - November 6, 2024

SONN announced stock split 1-8

BREAKING NEWS: $SONN SONN announced stock split 1-82024-09-30 09:01:52 ET Sonnet BioTherapeutics Inc (SONN) announced stock split at a...
whytestocks - September 30, 2024
View more Bullboard ››

Prospera Energy Inc.

Prospera Energy Inc.

Prospera Energy Inc. is an energy company based in Western Canada, specializing in the exploration, development, and ...
View More »